Assess Impact of Poly-L-lactic Acid on GLP1 Subjects
ConditionLaxity; Skin
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age25-65
SponsorGoldman, Butterwick, Fitzpatrick and Groff
About this trial
Clinical trial to evaluate treatments of double-dilute poly-L-lactic acid on abdominal skin laxity in GLP1 patients versus non GLP1 patients.
Eligibility criteria
Qualifiers
Adult women aged 25-65 years.
Fitzpatrick skin types I-IV.
Presence of mild to moderate skin laxity of abdomen, as determined by clinical investigators.
Stable weight for 3 months, with body mass index (BMI) of 27 or less.
Disqualifiers
The presence of severe abdominal skin laxity as determined by clinical investigators.
Still actively losing weight.
Pregnancy or planned pregnancy during the study or currently breastfeeding.
Any uncontrolled systemic disease.
Trial design
Treatments tested in this trial
- Sculptra Aesthetic
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov